Bladder, kidney, and other urologic cancers

Drug Name

• AFINITOR
• ALYMSYS
• AVASTIN
• BALVERSA
• BAVENCIO
• Bladder Cancer Risk Elevated in Statin Users
• CABOMETYX
• Cisplatin
• COSMEGEN
• DEPO-PROVERA
• Doxorubicin HCl
• Doxorubicin HCl Solution
• FDA Approves New First-Line Treatment for Advanced RCC
• FOTIVDA
• Higher Vitamin D Levels Reduce the Likelihood of Kidney Cancer
• IMFINZI
• INLYTA
• JELMYTO
• KEYTRUDA
• Kidney Cancer Linked to Adolescent Overweight, Obesity
• LENVIMA
• MVASI
• NEXAVAR
• OPDIVO
• PADCEV
• PROLEUKIN
• RCC Tumor Size Affects PN, Cryoablation Survival Outcomes
• Robotic Partial Nephrectomy May Be a Viable Option for Large Renal Tumors
• Standard of Care for mRCC May Change
• SUTENT
• Targeted RCC Therapies Benefit ‘Real World’ Medicare Patients
• TECENTRIQ
• TEPADINA
• Thiotepa
• TICE BCG
• TORISEL
• TRODELVY
• VALSTAR
• VEGZELMA
• Vincristine Sulfate PFS
• VOTRIENT
• WELIREG
• YERVOY
• ZIRABEV